FSA sets August date for sale of securitised derivatives to retail sector

Securitised derivatives, which include covered warrants and structured product certificates, are typically freely traded and listed on stock exchanges. They enable investors to gain exposure to a wide range of underlying products such as shares, indexes, commodities and interest rates without investing directly in the underlying product.

Firms selling or recommending securitised derivatives to private customers will need to provide a risk warning that will highlight the risks associated with

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

If you already have an account, please sign in here.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here